Discovery of Novel Human Constitutive Androstane Receptor Agonists with the Imidazo[1,2- a ]pyridine Structure
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.2c01140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Ivana Mejdrová und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic. Hauptthemen laut MEDLINE: Constitutive Androstane Receptor, Receptors, Steroid. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grantov? Agentura Cesk? Republiky, Akademie Ved Cesk? Republiky, Technologick? Agentura Cesk? Republiky.
Abstract (Originalsprache)
The nuclear constitutive androstane receptor (CAR, NR1I3) plays significant roles in many hepatic functions, such as fatty acid oxidation, biotransformation, liver regeneration, as well as clearance of steroid hormones, cholesterol, and bilirubin. CAR has been proposed as a hypothetical target receptor for metabolic or liver disease therapy. Currently known prototype high-affinity human CAR agonists such as CITCO (6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde-O-(3,4-dichlorobenzyl)oxime) have limited selectivity, activating the pregnane X receptor (PXR) receptor, a related receptor of the NR1I subfamily. We have discovered several derivatives of 3-(1H-1,2,3-triazol-4-yl)imidazo[1,2-a]pyridine that directly activate human CAR in nanomolar concentrations. While compound 39 regulates CAR target genes in humanized CAR mice as well as human hepatocytes, it does not activate other nuclear receptors and is nontoxic in cellular and genotoxic assays as well as in rodent toxicity studies. Our findings concerning potent human CAR agonists with in vivo activity reinforce the role of CAR as a possible therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.
- Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague, Czech Republic.
- 1st Medical Faculty, Charles University, Katerinska 32, 112 08 Prague, Czech Republic.
- Faculty of Military Health Sciences, University of Defense, Trebeska 1575, 500 01 Hradec Kralove, Czech Republic.
- Department of Internal Medicine VIII, University Hospital of Tübingen, 72076 Tübingen, Germany.
ORCID-Profile: Kryštof Škach, Ivona Pavkova, Radim Nencka
Förderung
- Grantov? Agentura Cesk? Republiky
- Akademie Ved Cesk? Republiky
- Technologick? Agentura Cesk? Republiky
- Ministerstvo Obrany Cesk? Republiky
- Czech Centre for Phenogenomics
Zitieren
APA
Mejdrová, I., Dušek, J., Škach, K., Stefela, A., Skoda, J., Chalupský, K., Dohnalová, K., Pavkova, I., Kronenberger, T., Rashidian, A., Smutná, L., Duchoslav, V., Smutny, T., Pávek, P., & Nencka, R. (2023). Discovery of Novel Human Constitutive Androstane Receptor Agonists with the Imidazo[1,2- a ]pyridine Structure. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c01140
Vancouver
Mejdrová I, Dušek J, Škach K, Stefela A, Skoda J, Chalupský K, et al. Discovery of Novel Human Constitutive Androstane Receptor Agonists with the Imidazo[1,2- a ]pyridine Structure. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c01140
BibTeX
@article{Mejdrov2023,
author = {Mejdrová, Ivana and Dušek, Jan and Škach, Kryštof and Stefela, Alžbeta and Skoda, Josef and Chalupský, Karel and Dohnalová, Klára and Pavkova, Ivona and Kronenberger, Thales and Rashidian, Azam and Smutná, Lucie and Duchoslav, Vojtěch and Smutny, Tomas and Pávek, Petr and Nencka, Radim},
title = {Discovery of Novel Human Constitutive Androstane Receptor Agonists with the Imidazo[1,2- a ]pyridine Structure},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.2c01140}
}
EUVIMED